Diabetic Retinopathy Market by Type and Management - Global Industry Analysis and Forecast To 2025

Las Vegas, Nevada, UNITED STATES


LAS VEGAS, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The global Diabetic Retinopathy Market is projected to be around $2.6 billion by 2025. This growth can be attributed to increase in prevalence of diabetes, increase in demand for early screening techniques and increase awareness about disease and available treatments among patients. Increasing incidence of diabetes caused blindness will further enhance the growth of market during forecast period. As per International Diabetes Federation (IDF) 415 million people worldwide suffered from diabetes and diabetes related complications as of 2015 and this number is expected to reach 642 million by 2040. Diabetic retinopathy is characterized by neovascularization of retina, blurred vision and moderate to severe eye pain. This further leads to retinal detachment and complete loss of vision. Such high complications will lead to increase in demand for methods to treat diabetes retinopathy which will drive the market during forecast period However, dearth of skilled professionals and poor insurance facilities are restraining the market growth.

Major Key Player

Bayer Healthcare

Novartis AG

Actavis PLC

ThromboGenics

irnaomics Incorporation

Genentech

Glycadia Pharmaceuticals

Regeneron Pharmaceuticals Inc.

Alimera Sciences

Ampio Pharmaceuticals.

Get complete access to Reports: http://www.crystalmarketresearch.com/report/diabetic-retinopathy-market

Diabetic Retinopathy Market is segmented as follows –

By Type:

  • Proliferative Diabetic Retinopathy
  • Diabetic Macular Edema

By Management:

  • Anti VEGF Drugs
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates

Get Sample of this Report @ http://www.crystalmarketresearch.com/report-sample/HC0622

Table of Contents

1. Introduction
2. Executive Summary
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. High Prevalence of Diabetes
3.3.1.2. Rise in Demand for Early Detection Techniques
3.3.1.3. Increased Awareness about Diabetes
3.3.2. Restraints
3.3.2.1. Dearth of Skilled Professionals
3.3.2.2. Poor Insurance Facilities
3.3.3. Opportunities
3.3.3.1. Emerging Market to Offer Lucrative Growth Opportunities
3.4. Industry Trends
4. Diabetic Retinopathy Market, By Product
5. Diabetic Retinopathy Market, By Application
6. Diabetic Retinopathy Market, By Region
7. Company Profiles

Buy Report @ http://www.crystalmarketresearch.com/checkout/22

About Us:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Website: www.crystalmarketresearch.com